Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT04701632 Active, not recruiting - Wound Clinical Trials

Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool

Start date: October 28, 2019
Phase:
Study type: Observational

The objective of the study is to complete a retrospective chart review of subjects who were treated at the Wound Care Clinic at Methodist Dallas Medical Center, presented for treatment between June 2018 and February 2019, and were administered the PHQ-9. The study aims to measure the prevalence of depression in this sample, feasibility of using PHQ-9 in this patient population, and identifying variables and functional impairment associated with clinically significant depression.

NCT ID: NCT04681508 Active, not recruiting - Acute Kidney Injury Clinical Trials

MINS, AKI and Pulmonary Pathology in Patients Undergoing Acute Abdominal Surgery

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Explorative study to investigate potential predictors of myocardial injury, acute kidney injury and pulmonary disorder after acute high-risk abdominal surgery.

NCT ID: NCT04672668 Active, not recruiting - Clinical trials for Wound Heal, Duplex Volume Flow

Correlation Between the Volume Flow of the CFA After Angioplasty of Critical Ischemic Limb and Wound Healing

Start date: December 13, 2020
Phase:
Study type: Observational [Patient Registry]

in our study we are examining the volume flow of the common femoral artery before and after angigraphy of a critical ischemic limb, as a predictor for wound healing after the treatment

NCT ID: NCT04606056 Active, not recruiting - Acute Kidney Injury Clinical Trials

Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans

Start date: May 31, 2023
Phase:
Study type: Observational

Intravenous iodinated contrast media is commonly used to enhance diagnostic yield of computer tomography (CT) scans in clinical medicine. However, the perceived risk of contrast-induced nephropathy (CIN) frequently limits its use. While CIN is often self-limiting, it can cause significant morbidity by prolonging admissions and rendering an at-risk individual dialysis dependent. CIN has long been observed and described in clinical studies. There is ample data on CIN after administration of intraarterial contrast, but evidence is less compelling when it comes to intravenous contrast. Increasing studies have called into question the actual risk of intravenous contrast media. Expert panels are suggesting that the risk could have been overstated, leading to contrast being withheld when indicated. There is paucity of local data on this particular issue. More real world data on the actual incidence and risk factors of AKI will be helpful to clinicians. The investigators plan to conduct a single center, retrospective study, to determine the incidence and risk factors of post contrast AKI in contrast enhanced CT scans.

NCT ID: NCT04584957 Active, not recruiting - Gynecologic Cancer Clinical Trials

Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)

GO-VAC
Start date: September 18, 2020
Phase: N/A
Study type: Interventional

A prospective controlled randomized study aimed to prospectively evaluate, the impact and effectiveness of clean incision prophylactic vacuum negative pressure therapy on wound healing (ciNPWT) in women at high risk of developing wound complications who undergo major gynecologic surgery. Gynecologic Oncology patients appear to be more at risk of developing wound complications than the general surgery population, reaching infection rates of 36 vs. 24 % that become 40 and 60% for obese and morbidly obese patients, respectively. Data about the use of ciNPWT are few, controversial and are of poor quality. No randomized, controlled trials have yet been reported in support of the use of ciNPWT in the gynecologic population.

NCT ID: NCT04583293 Active, not recruiting - Acute Kidney Injury Clinical Trials

Acute kIDnEy Injury in coviD-19

AIDED
Start date: October 8, 2020
Phase:
Study type: Observational

This is a prospective observational parallel group cohort study that will aim to recruit 220 participants who were admitted to the hospital with COVID-19 between 1st March 2020 and 30th June 2020 (Group A - 110 participants who had COVID-19 with AKIÍž Group B - 110 participants who had COVID-19 without AKI). Data from groups A and B will be compared with AKI and non-AKI groups from an existing study database (ARID study, n=1125) who were recruited before the outbreak of the COVID-19 pandemic (recruitment 2013-2016) and who have all completed at least three years of follow up. Participants who have recovered from COVID-19 will be matched for analysis to participants from the ARID study for AKI status, baseline estimated glomerular filtration rate (eGFR) stage, age (± 5 years) and presence of diabetes. Potential participants will receive a letter of invitation along with a comprehensive participant information sheet (PIS).

NCT ID: NCT04572906 Active, not recruiting - Clinical trials for Peripheral Nerve Injuries

Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

Start date: September 25, 2020
Phase: Phase 2
Study type: Interventional

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.

NCT ID: NCT04544761 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Resilience in Persons Following Spinal Cord Injury

Start date: September 25, 2020
Phase:
Study type: Observational

This study aims to quantify resilience in survivors of a spinal cord injury. The study will consist of structured interviews and self-reported surveys. We will look for common themes between participants at different stages of injury (1-5 years, 5-15 years, >15 Years).

NCT ID: NCT04534972 Active, not recruiting - Critical Illness Clinical Trials

Strategy to Avoid Excessive Oxygen in Major Burn Patients

SAVE-O2
Start date: April 15, 2021
Phase: Phase 3
Study type: Interventional

The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.

NCT ID: NCT04534959 Active, not recruiting - Critical Illness Clinical Trials

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

SAVE-O2
Start date: October 15, 2020
Phase: Phase 3
Study type: Interventional

The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in critically injured patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.